Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. CHIU WC, Wu ZF, Lee MS, Chen JY, et al
    Propofol-based total intravenous anesthesia is associated with less postoperative recurrence than desflurane anesthesia in thyroid cancer surgery.
    PLoS One. 2024;19:e0296169.
    >> Share

  2. MULLAN LJ, Blackburn NE, Lorimer J, Semple CJ, et al
    Evaluating the effects of lymphoedema management strategies on functional status and health-related quality of life following treatment for head and neck cancer: Protocol for a systematic review.
    PLoS One. 2024;19:e0297757.
    >> Share

  3. KHONGWIROTPHAN S, Oonsiri S, Kitpanit S, Prayongrat A, et al
    Multimodality radiomics for tumor prognosis in nasopharyngeal carcinoma.
    PLoS One. 2024;19:e0298111.
    >> Share

  4. NGUYEN V, Schrank TP, Major MB, Weissman BE, et al
    ARID1A loss is associated with increased NRF2 signaling in human head and neck squamous cell carcinomas.
    PLoS One. 2024;19:e0297741.
    >> Share

  5. WAKISAKA N, Moriyama-Kita M, Kondo S, Kobayashi E, et al
    Lymph node metastasis regulation by peritumoral tonsillar tissue mitochondria-related pathway activation in oropharyngeal cancer.
    PLoS One. 2024;19:e0299750.
    >> Share

  6. KUO CY, Tsai CH, Wu JK, Cheng SP, et al
    Sublethal thermal stress promotes migration and invasion of thyroid cancer cells.
    PLoS One. 2024;19:e0298903.
    >> Share

  7. LU H, Bei Y, Wang C, Deng X, et al
    A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC).
    PLoS One. 2024;19:e0298792.
    >> Share

  8. GUNNING JA, Gilman KE, Zuniga TM, Simpson RJ, et al
    Parotid glands have a dysregulated immune response following radiation therapy.
    PLoS One. 2024;19:e0297387.
    >> Share

  9. WANG P, Soh KL, Japar SB, Khazaai HB, et al
    Assessing malnutrition in patients with nasopharyngeal carcinoma: Diagnostic protocol for the development and validation of a new nutritional assessment tool.
    PLoS One. 2024;19:e0300067.
    >> Share

  10. AN R, Gu YX, Ni XH, Lei Y, et al
    The feasibility and clinical significance of lateral approach thyroidectomy.
    PLoS One. 2024;19:e0300604.
    >> Share

  11. JIN X, Yin Z, Li X, Guo H, et al
    TIM3 activates the ERK1/2 pathway to promote invasion and migration of thyroid tumors.
    PLoS One. 2024;19:e0297695.
    >> Share

  12. PAO TH, Chen YY, Chang WL, Wu SY, et al
    Lymph node volume predicts survival in esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy and surgery.
    PLoS One. 2024;19:e0300173.
    >> Share

  13. RUSANEN P, Marttila E, Amatya SB, Hagstrom J, et al
    Expression of Toll-like receptors in oral squamous cell carcinoma.
    PLoS One. 2024;19:e0300437.
    >> Share

  14. MONTAGNOLI DRABS, Leite VF, Godoy YS, Lafeta VM, et al
    Can predictive factors determine the time to treatment initiation for oral and oropharyngeal cancer? A classification and regression tree analysis.
    PLoS One. 2024;19:e0302370.
    >> Share

  15. SASAKI A, Takeda D, Kawai H, Tadokoro Y, et al
    Transcutaneous carbon dioxide suppresses skeletal muscle atrophy in a mouse model of oral squamous cell carcinoma.
    PLoS One. 2024;19:e0302194.
    >> Share

  16. XIE L, He L, Zhang W, Wang H, et al
    Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
    PLoS One. 2024;19:e0298631.
    >> Share

  17. JIANG W, Xu S, Li P
    SLC2A3 promotes tumor progression through lactic acid-promoted TGF-beta signaling pathway in oral squamous cell carcinoma.
    PLoS One. 2024;19:e0301724.
    >> Share

  18. TALANI C, Hogmo A, Laurell G, Makitie A, et al
    Six-month mortality has decreased for patients with curative treatment intent for head and neck cancer in Sweden.
    PLoS One. 2024;19:e0296534.
    >> Share

  19. ZHANG X, Yu J, Zhu J, Wei H, et al
    A meta-analysis of unilateral axillary approach for robotic surgery compared with open surgery for differentiated thyroid carcinoma.
    PLoS One. 2024;19:e0298153.
    >> Share

    January 2023
  20. HOSSAIN MA, Sohel M, Rahman MH, Hasan MI, et al
    Bioinformatics and In silico approaches to identify novel biomarkers and key pathways for cancers that are linked to the progression of female infertility: A comprehensive approach for drug discovery.
    PLoS One. 2023;18:e0265746.
    >> Share

  21. GONZALEZ-CALLEJO P, Guo Z, Ziglari T, Claudio NM, et al
    Cancer stem cell-derived extracellular vesicles preferentially target MHC-II-macrophages and PD1+ T cells in the tumor microenvironment.
    PLoS One. 2023;18:e0279400.
    >> Share

  22. JUN M, Pinto H, Le QT, Quon A, et al
    In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation.
    PLoS One. 2023;18:e0276651.
    >> Share

  23. BECKER JN, Hermann R, Wichmann J, Sonnhoff M, et al
    Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy.
    PLoS One. 2023;18:e0282015.
    >> Share

  24. LUETRAGOON T, Thongsri Y, Daotak K, Potup P, et al
    Anti-proliferative and immunomodulatory properties of kaffir lime leaves and bioactive compounds on macrophages co-cultured with squamous cell carcinoma.
    PLoS One. 2023;18:e0281378.
    >> Share

  25. LEE RH, Roy R, Li H, Hechmer A, et al
    Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts.
    PLoS One. 2023;18:e0282177.
    >> Share

  26. ZHANG L, Yu S, Yin X, Tu M, et al
    MiR-942-5p inhibits tumor migration and invasion through targeting CST1 in esophageal squamous cell carcinoma.
    PLoS One. 2023;18:e0277006.
    >> Share

  27. YORAM F, Dharsee N, Mkoka DA, Maunda K, et al
    Radiation therapists' perceptions of thermoplastic mask use for head and neck cancer patients undergoing radiotherapy at Ocean Road Cancer Institute in Tanzania: A qualitative study.
    PLoS One. 2023;18:e0282160.
    >> Share

  28. LI PJ, Chen M, Tian Y
    T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study.
    PLoS One. 2023;18:e0279252.
    >> Share

  29. GOLDSCHMIDT S, Stewart N, Ober C, Bell C, et al
    Contrast-enhanced and indirect computed tomography lymphangiography accurately identifies the cervical lymphocenter at risk for metastasis in pet dogs with spontaneously occurring oral neoplasia.
    PLoS One. 2023;18:e0282500.
    >> Share

  30. SHIN HI, Cho KJ, Kim MS, Joo YH, et al
    Predictive factors of distant metastasis in surgically treated HPV-positive tonsil cancer.
    PLoS One. 2023;18:e0283368.
    >> Share

  31. LIANG Z, Wu M, Wang P, Quan H, et al
    Updated racial disparities in incidence, clinicopathological features and prognosis of hypopharyngeal squamous carcinoma in the United States.
    PLoS One. 2023;18:e0282603.
    >> Share

  32. TRAMA A, Licitra L, Cavalieri S, Bonfarnuzzo S, et al
    The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers.
    PLoS One. 2023;18:e0283071.
    >> Share

  33. HONDA K, Lee SW, Kawai M, Tanaka R, et al
    An individual's physique is associated with the length of the reconstruction route via the retrosternal approach.
    PLoS One. 2023;18:e0283890.
    >> Share

  34. ALESSANDRO S, Paradiso E, Lazzaretti C, Sperduti S, et al
    Intracellular cGMP increase is not involved in thyroid cancer cell death.
    PLoS One. 2023;18:e0283888.
    >> Share

  35. YANG F, Zhang J, Zhao Z, Liu Y, et al
    Artemisinin suppresses aerobic glycolysis in thyroid cancer cells by downregulating HIF-1a, which is increased by the XIST/miR-93/HIF-1a pathway.
    PLoS One. 2023;18:e0284242.
    >> Share

  36. BROOKS PJ, Malkin EZ, De Michino S, Bratman SV, et al
    Isolation of salivary cell-free DNA for cancer detection.
    PLoS One. 2023;18:e0285214.
    >> Share

  37. ZHANG S, Chen J, Liu Z, Wang X, et al
    Key theories and technologies and implementation mechanism of parallel computing for ternary optical computer.
    PLoS One. 2023;18:e0284700.
    >> Share

  38. TAKEGAWA N, Hirabayashi T, Tanaka S, Nishikawa M, et al
    The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer.
    PLoS One. 2023;18:e0285365.
    >> Share

  39. MENG Z, Zhu L, Liu W, Yang W, et al
    T cell-mediated tumor killing patterns in head and neck squamous cell carcinoma identify novel molecular subtypes, with prognosis and therapeutic implications.
    PLoS One. 2023;18:e0285832.
    >> Share

  40. KHAN RA, Devi KR, Pratim Barman M, Bhagawati M, et al
    Bacteria in the oral cavity of individuals consuming intoxicating substances.
    PLoS One. 2023;18:e0285753.
    >> Share

  41. VAINER G, Huang L, Emancipator K, Nuti S, et al
    Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications.
    PLoS One. 2023;18:e0285764.
    >> Share

  42. CUI Y, Wu Y, Zhu Y, Liu W, et al
    The possible molecular mechanism underlying the involvement of the variable shear factor QKI in the epithelial-mesenchymal transformation of oesophageal cancer.
    PLoS One. 2023;18:e0288403.
    >> Share

  43. LEE H, Lee JW, Cho HW, Choe YS, et al
    Methionine metabolism and endocrine function of the pituitary gland in patients with suprasellar germinoma.
    PLoS One. 2023;18:e0288528.
    >> Share

  44. HASSAN MZO, Tawakol A, Wang Y, Alvi RM, et al
    Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival.
    PLoS One. 2023;18:e0279235.
    >> Share

  45. HU H, Jiang H, Zhu Z, Yin H, et al
    Analysis of the anatomical distribution of HPV genotypes in head and neck squamous papillomas.
    PLoS One. 2023;18:e0290004.
    >> Share

  46. TADOKORO Y, Takeda D, Murakami A, Yatagai N, et al
    Transcutaneous carbon dioxide application suppresses the expression of cancer-associated fibroblasts markers in oral squamous cell carcinoma xenograft mouse model.
    PLoS One. 2023;18:e0290357.
    >> Share

  47. SMITH PD, Murray M, Bailey T, Peterson CE, et al
    A community-based participatory protocol to improving communication with Black men about oral and pharyngeal cancers: Research protocol.
    PLoS One. 2023;18:e0288478.
    >> Share

  48. MIDGLEY AW, Levy AR, Rogers SN, Brooker RC, et al
    ACTivity as medicine In Oncology for Head and Neck (ACTIOHN): Protocol for a feasibility study investigating a patient-centred approach to exercise for people with head and neck cancer.
    PLoS One. 2023;18:e0289911.
    >> Share

  49. YANG J, Zhang J, Chen J, Yang X, et al
    Thymidylate synthase promotes esophageal squamous cell carcinoma growth by relieving oxidative stress through activating nuclear factor erythroid 2-related factor 2 expression.
    PLoS One. 2023;18:e0290264.
    >> Share

  50. WU Q, Chang Y, Yang C, Liu H, et al
    Adjuvant chemotherapy or no adjuvant chemotherapy? A prediction model for the risk stratification of recurrence or metastasis of nasopharyngeal carcinoma combining MRI radiomics with clinical factors.
    PLoS One. 2023;18:e0287031.
    >> Share

  51. MASROUR M, Khanmohammadi S, Fallahtafti P, Rezaei N, et al
    Long non-coding RNA as a potential diagnostic biomarker in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0291921.
    >> Share

  52. COSTA EM, Magalhaes Rodrigues ES, de Sousa FS, Pimentel FB, et al
    The Brazilian National Oral Health Policy and oral cancer mortality trends: An autoregressive integrated moving average (ARIMA) model.
    PLoS One. 2023;18:e0291609.
    >> Share

  53. JUNG S, Kim B, Lee SY, Chang WI, et al
    Novel tongue-positioning device to reduce tongue motions during radiation therapy for head and neck cancer: Geometric and dosimetric evaluation.
    PLoS One. 2023;18:e0291712.
    >> Share

  54. LIU Y, Yan M
    Trends in all causes and cause specific mortality attributable to ambient particulate matter pollution in China from 1990 to 2019: A secondary data analysis study.
    PLoS One. 2023;18:e0291262.
    >> Share

  55. MAEKAWA N, Konnai S, Hosoya K, Kim S, et al
    Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.
    PLoS One. 2023;18:e0291727.
    >> Share

  56. IEZADI S, Ebrahimi N, Ghamari SH, Esfahani Z, et al
    Global and regional quality of care index (QCI) by gender and age in oesophageal cancer: A systematic analysis of the Global Burden of Disease Study 1990-2019.
    PLoS One. 2023;18:e0292348.
    >> Share

  57. NGUYEN TPA, Gautam S, Mahato S, Jensen OC, et al
    Overview of oral health status and associated risk factors in maritime settings: An updated systematic review.
    PLoS One. 2023;18:e0293118.
    >> Share

  58. SHANG F, Liu X, Ren X, Li Y, et al
    Competing-risks model for predicting the prognostic value of lymph nodes in medullary thyroid carcinoma.
    PLoS One. 2023;18:e0292488.
    >> Share

  59. KHAN A, Fawzy WMS, Habib SS, Sultan M, et al
    Novel and pragmatic exploration of variation in glottic parameters in non-parallel versus parallel vocal cord CT planes with potential reporting pitfalls.
    PLoS One. 2023;18:e0293659.
    >> Share

  60. GU H, Li T, Beeraka NM, Zheng Y, et al
    Molecular classification of human papilloma virus-negative head and neck squamous cell carcinomas: Cell cycle-based classifier and prognostic signature.
    PLoS One. 2023;18:e0286414.
    >> Share

  61. BRIGDEN T, Mitchell C, Redrup Hill E, Hall A, et al
    Ethical and legal implications of implementing risk algorithms for early detection and screening for oesophageal cancer, now and in the future.
    PLoS One. 2023;18:e0293576.
    >> Share

  62. KANZOW P, Mielke K, Haupt F, Wiegand S, et al
    Oral health in patients with different sites of head and neck squamous cell carcinoma is not different.
    PLoS One. 2023;18:e0293665.
    >> Share

  63. MUANGWONG P, Homkham N, Narueban W, Tadadoltip C, et al
    Longitudinal measurements of neutrophil-to-lymphocyte ratio in nasopharyngeal cancer treated with concurrent chemoradiotherapy.
    PLoS One. 2023;18:e0292591.
    >> Share

  64. HOSSEINIYAN KHATIBI SM, Zununi Vahed S, Homaei Rad H, Emdadi M, et al
    Uncovering key molecular mechanisms in the early and late-stage of papillary thyroid carcinoma using association rule mining algorithm.
    PLoS One. 2023;18:e0293335.
    >> Share

  65. KANANKULAM VELLIANGIRI S, Ballal S, Prasad Yadhav M, Tripathi M, et al
    A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastases.
    PLoS One. 2023;18:e0294343.
    >> Share

  66. HEO J, Lee S, Park J, Yang H, et al
    Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
    PLoS One. 2023;18:e0294145.
    >> Share

  67. ZAMANI N, Szymiczek A, Shakeri R, Poustchi H, et al
    A Single nucleotide polymorphism in the ALDH2 gene modifies the risk of esophageal squamous cell carcinoma in BRCA2 p.K3326* carriers.
    PLoS One. 2023;18:e0292611.
    >> Share

  68. SHETAKE NG, Kumar A, Huilgol N, Pandey BN, et al
    Diagnostic potential of serum HSP90 beta for HNSCC and its therapeutic prognosis after local hyperthermia therapy.
    PLoS One. 2023;18:e0281919.
    >> Share

  69. ZOU M, Liang Q, Zhang W, Zhu Y, et al
    Causal association between dietary factors and esophageal diseases: A Mendelian randomization study.
    PLoS One. 2023;18:e0292113.
    >> Share

  70. SCHAEFFERS AWMA, Devriese LA, van Gils CH, Dankbaar JW, et al
    Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol.
    PLoS One. 2023;18:e0294147.
    >> Share

  71. SONG WJ, Um IC, Kwon SR, Lee JH, et al
    Predictive factors of lymph node metastasis in papillary thyroid cancer.
    PLoS One. 2023;18:e0294594.
    >> Share

  72. BUSS LG, De Oliveira Pessoa D, Snider JM, Padi M, et al
    Metabolomics analysis of pathways underlying radiation-induced salivary gland dysfunction stages.
    PLoS One. 2023;18:e0294355.
    >> Share

  73. TATEAI Y, Kawakami K, Teramae M, Fukuda N, et al
    Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma.
    PLoS One. 2023;18:e0294320.
    >> Share

  74. ALOLAYAN WR, Rieger JM, Yoon MN
    Head and neck cancer treatment outcome priorities: A multi-perspective concept mapping study.
    PLoS One. 2023;18:e0294712.
    >> Share

  75. MIRAKI FERIZ A, Bahraini F, Khosrojerdi A, Azarkar S, et al
    Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy.
    PLoS One. 2023;18:e0295863.
    >> Share

  76. SACCO A, Battaglia AM, Santamaria G, Buffone C, et al
    SOX2 promotes a cancer stem cell-like phenotype and local spreading in oral squamous cell carcinoma.
    PLoS One. 2023;18:e0293475.
    >> Share

  77. FANG Q, Dai L, Zhang X, Luo R, et al
    Number and ratio of metastatic lymph nodes impacts the prognosis of submandibular gland cancer.
    PLoS One. 2023;18:e0296040.
    >> Share

    January 2022
  78. ZHU C, Zhong L, Lin M, Tian C, et al
    The value of TI-RADS combined with superb micro-vascular imagine in distinguishing benign and malignant thyroid nodules: A meta-analysis.
    PLoS One. 2022;17:e0261521.
    >> Share

  79. WANG SW, Chan LP, Wang LF, Wu CW, et al
    Secondary primary malignancy in patients with head and neck squamous cell carcinoma: 27-year experience from the perspective of diagnostic tools.
    PLoS One. 2022;17:e0263773.
    >> Share

  80. KANAMARLAPUDI V, Tamaddon-Jahromi S, Murphy K
    ADP-ribosylation factor 6 expression increase in oesophageal adenocarcinoma suggests a potential biomarker role for it.
    PLoS One. 2022;17:e0263845.
    >> Share

  81. MORNA MT, Tuoyire DA, Jimah BB, Eliason S, et al
    Prevalence and characterization of asymptomatic thyroid nodules in Assin North District, Ghana.
    PLoS One. 2022;17:e0263365.
    >> Share

  82. SUZUKI S, Toyoma S, Kawasaki Y, Yamada T, et al
    Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0262549.
    >> Share

  83. ZHANG X, Lee VCS, Rong J, Liu F, et al
    Multi-channel convolutional neural network architectures for thyroid cancer detection.
    PLoS One. 2022;17:e0262128.
    >> Share

  84. VERYASKINA YA, Titov SE, Ivanov MK, Ruzankin PS, et al
    Selection of reference genes for quantitative analysis of microRNA expression in three different types of cancer.
    PLoS One. 2022;17:e0254304.
    >> Share

  85. HO SY, Kao WC, Hsiao SY, Chiu SF, et al
    Retrospective analysis of adjuvant radiotherapy in oral cavity or oropharyngeal cancer: Feasibility of omitting lower-neck irradiation.
    PLoS One. 2022;17:e0266678.
    >> Share

  86. ABUSALAH MAH, Irekeola AA, Hanim Shueb R, Jarrar M, et al
    Prognostic Epstein-Barr Virus (EBV) miRNA biomarkers for survival outcome in EBV-associated epithelial malignancies: Systematic review and meta-analysis.
    PLoS One. 2022;17:e0266893.
    >> Share

  87. SHENG S, Su W, Mao D, Li C, et al
    MicroRNA-21 induces cisplatin resistance in head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0267017.
    >> Share

  88. ROUMANS CAM, Spaander MCW, Lansdorp-Vogelaar I, Biermann K, et al
    A personalized and dynamic risk estimation model: The new paradigm in Barrett's esophagus surveillance.
    PLoS One. 2022;17:e0267503.
    >> Share

  89. BADRI P, Baracos V, Ganatra S, Lai H, et al
    Retrospective study of factors associated with late detection of oral cancer in alberta: A qualitative study.
    PLoS One. 2022;17:e0266558.
    >> Share

  90. RIBEIRO-ROTTA RF, Rosa EA, Milani V, Dias NR, et al
    The cost of oral cancer: A systematic review.
    PLoS One. 2022;17:e0266346.
    >> Share

  91. ELLIS BG, Whitley CA, Triantafyllou A, Gunning PJ, et al
    Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
    PLoS One. 2022;17:e0266043.
    >> Share

  92. XIE L, Shang Z
    Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study.
    PLoS One. 2022;17:e0265950.
    >> Share

  93. ALI A, Rumbold AR, Kapellas K, Lassi ZS, et al
    Association between self-reported periodontitis and high-risk oral human papillomavirus infection among Indigenous South Australians: A cross-sectional study.
    PLoS One. 2022;17:e0265840.
    >> Share

  94. ZHANG ZJ, Shi LL, Hong XH, Xiao BY, et al
    A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.
    PLoS One. 2022;17:e0265551.
    >> Share

  95. NIK JAAFAR NR, Hamdan NA, Abd Hamid N, Rajandram RK, et al
    Posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients.
    PLoS One. 2022;17:e0265502.
    >> Share

  96. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    >> Share

  97. GRASS JK, Kusters N, Kemper M, Tintrup J, et al
    Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience.
    PLoS One. 2022;17:e0265093.
    >> Share

  98. BROUWER AF, Campredon LP, Walline HM, Marinelli BM, et al
    Prevalence and determinants of oral and cervicogenital HPV infection: Baseline analysis of the Michigan HPV and Oropharyngeal Cancer (MHOC) cohort study.
    PLoS One. 2022;17:e0268104.
    >> Share

  99. MIAO L, Lv X, Huang C, Li P, et al
    Long-term oncological outcomes after oral cancer surgery using propofol-based total intravenous anesthesia versus sevoflurane-based inhalation anesthesia: A retrospective cohort study.
    PLoS One. 2022;17:e0268473.
    >> Share

  100. CHANGKUN Z, Bishwajit G, Ji L, Tang S, et al
    Sociodemographic correlates of cervix, breast and oral cancer screening among Indian women.
    PLoS One. 2022;17:e0265881.
    >> Share

  101. ADNAN Y, Ali SMA, Awan MS, Idress R, et al
    Hormone receptors AR, ER, PR and growth factor receptor Her-2 expression in oral squamous cell carcinoma: Correlation with overall survival, disease-free survival and 10-year survival in a high-risk population.
    PLoS One. 2022;17:e0267300.
    >> Share

  102. ZHANG Z, Leong Bin Abdullah MFI, Shari NI, Lu P, et al
    Acceptance and commitment therapy versus mindfulness-based stress reduction for newly diagnosed head and neck cancer patients: A randomized controlled trial assessing efficacy for positive psychology, depression, anxiety, and quality of life.
    PLoS One. 2022;17:e0267887.
    >> Share

  103. BLATT S, Kruger M, Rump C, Zimmer S, et al
    Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma.
    PLoS One. 2022;17:e0269136.
    >> Share

  104. KOSKINEN A, Hemminki O, Forsti A, Hemminki K, et al
    Incidence and survival in laryngeal and lung cancers in Finland and Sweden through a half century.
    PLoS One. 2022;17:e0268922.
    >> Share

  105. HU C, Fan J, He G, Dong C, et al
    Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma.
    PLoS One. 2022;17:e0269166.
    >> Share

  106. TANG Q, Pan W, Peng L
    Association between Hashimoto thyroiditis and clinical outcomes of papillary thyroid carcinoma: A meta-analysis.
    PLoS One. 2022;17:e0269995.
    >> Share

  107. LIANG Y, Huang X, Song Z, Yang Y, et al
    Clinical study of ultrasonic evaluation of T/N staging of differentiated thyroid carcinoma using AJCC 8th staging criteria.
    PLoS One. 2022;17:e0269994.
    >> Share

  108. DU Q, Xiao RD, Luo RG, Xie JB, et al
    Construction of long non-coding RNA- and microRNA-mediated competing endogenous RNA networks in alcohol-related esophageal cancer.
    PLoS One. 2022;17:e0269742.
    >> Share

  109. UEDA T, Yumii K, Urabe Y, Chikuie N, et al
    Swallowing function after transoral surgery for laryngopharyngeal cancer.
    PLoS One. 2022;17:e0270509.
    >> Share

  110. MARBANIANG I, Joshi S, Sangle S, Khaire S, et al
    Smokeless tobacco use and oral potentially malignant disorders among people living with HIV (PLHIV) in Pune, India: Implications for oral cancer screening in PLHIV.
    PLoS One. 2022;17:e0270876.
    >> Share

  111. WU L, Jiang C, Zhu Z, Sun Y, et al
    Prognostic role of PD-L1 expression in patients with salivary gland carcinoma: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0272080.
    >> Share

  112. AHN HS, Kim HS, Hong MJ
    Ultrasonographic and cytologic assessments of follicular neoplasms of the thyroid: Predictive features differentiating follicular carcinoma from follicular adenoma.
    PLoS One. 2022;17:e0271437.
    >> Share

  113. WANG B, Jiang W, Zheng X, Han Y, et al
    Research on a Weighted Gene Co-expression Network Analysis method for mining pathogenic genes in thyroid cancer.
    PLoS One. 2022;17:e0272403.
    >> Share

  114. WAKASAKI T, Manako T, Yasumatsu R, Hara H, et al
    Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study.
    PLoS One. 2022;17:e0271907.
    >> Share

  115. WANG Z, Luo J, Zhang Y, Xun P, et al
    Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis.
    PLoS One. 2022;17:e0271038.
    >> Share

  116. STENMAN S, Linder N, Lundin M, Haglund C, et al
    A deep learning-based algorithm for tall cell detection in papillary thyroid carcinoma.
    PLoS One. 2022;17:e0272696.
    >> Share

  117. GUO Y, Xu M, Lou Y, Yuan Y, et al
    Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for esophageal squamous cell cancer: A meta-analysis.
    PLoS One. 2022;17:e0271242.
    >> Share

  118. ZHONG L, Wang C
    Diagnostic accuracy of S-Detect in distinguishing benign and malignant thyroid nodules: A meta-analysis.
    PLoS One. 2022;17:e0272149.
    >> Share

  119. CHOI KH, Song JH, Hong JH, Lee YS, et al
    Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment.
    PLoS One. 2022;17:e0273059.
    >> Share

  120. WARIN K, Limprasert W, Suebnukarn S, Jinaporntham S, et al
    AI-based analysis of oral lesions using novel deep convolutional neural networks for early detection of oral cancer.
    PLoS One. 2022;17:e0273508.
    >> Share

  121. LIU Q, Du J, Li Y, Peng G, et al
    Uncovering nasopharyngeal carcinoma from chronic rhinosinusitis and healthy subjects using routine medical tests via machine learning.
    PLoS One. 2022;17:e0274263.
    >> Share

  122. JOUHI L, Sikio J, Suomalainen A, Mroueh R, et al
    Dental health in patients with and without HPV-positive oropharyngeal and tongue cancer.
    PLoS One. 2022;17:e0274813.
    >> Share

  123. HUR JY, Ku BM, Park S, Jung HA, et al
    Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
    PLoS One. 2022;17:e0274830.
    >> Share

  124. CHANG YL, Cheng YF, Chen HS, Wu SC, et al
    Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
    PLoS One. 2022;17:e0271338.
    >> Share

  125. CABUZU D, Ramakrishnan SK, Moor MB, Harmacek D, et al
    Loss of Ecrg4 improves calcium oxalate nephropathy.
    PLoS One. 2022;17:e0275972.
    >> Share

  126. ZHU Z, Yu S, Niu K, Wang P, et al
    LGR5 promotes invasion and migration by regulating YAP activity in hypopharyngeal squamous cell carcinoma cells under inflammatory condition.
    PLoS One. 2022;17:e0275679.
    >> Share

  127. TAKENAKA Y, Uno A, Tanaka H, Takemoto N, et al
    Radiation vs surgery for early-stage laryngeal verrucous carcinoma: A population-based propensity score matched-study.
    PLoS One. 2022;17:e0275271.
    >> Share

  128. LIN CH, Chuang HN, Hsiao TH, Kumar VB, et al
    AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma.
    PLoS One. 2022;17:e0276990.
    >> Share

  129. PANDA S, Sakthivel P, Gurusamy KS, Sharma A, et al
    Treatment options for resectable hypopharyngeal squamous cell carcinoma: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0277460.
    >> Share

  130. JOVANOVIC N, Chinnery T, Mattonen SA, Palma DA, et al
    Sarcopenia in head and neck cancer: A scoping review.
    PLoS One. 2022;17:e0278135.
    >> Share

  131. GANGIL T, Sharan K, Rao BD, Palanisamy K, et al
    Utility of adding Radiomics to clinical features in predicting the outcomes of radiotherapy for head and neck cancer using machine learning.
    PLoS One. 2022;17:e0277168.
    >> Share

  132. CAI Y, Zhang Y, Cao W, Hou F, et al
    Preliminary validation of the Chinese version of the Shame and Stigma Scale among patients with facial disfigurement from nasopharyngeal carcinoma.
    PLoS One. 2022;17:e0279290.
    >> Share

    January 2021
  133. MATSUOKA Y, Al-Shareef H, Kogo M, Nakahara H, et al
    Effects of decreased Rac activity and malignant state on oral squamous cell carcinoma in vitro.
    PLoS One. 2021;16:e0212323.
    >> Share

  134. HE L, Zhao W, Xia Z, Su A, et al
    Comparative efficacy of different ultrasound-guided ablation for the treatment of benign thyroid nodules: Systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0243864.
    >> Share

  135. CHIANG TE, Lin YC, Wu CT, Yang CY, et al
    Comparison of the accuracy of diagnoses of oral potentially malignant disorders with dysplasia by a general dental clinician and a specialist using the Taiwanese Nationwide Oral Mucosal Screening Program.
    PLoS One. 2021;16:e0244740.
    >> Share

  136. VERZA FA, Valente VB, Oliveira LK, Kayahara GM, et al
    Social isolation stress facilitates chemically induced oral carcinogenesis.
    PLoS One. 2021;16:e0245190.
    >> Share

  137. WANG C, Lin M, Zhong L, Tian C, et al
    The value of TI-RADS combined with superb microvascular imaging in distinguishing thyroid nodules: A protocol for systematic review and meta-analysis.
    PLoS One. 2021;16:e0245035.
    >> Share

  138. CHUANG FC, Wang CC, Chen JH, Hwang TZ, et al
    PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy.
    PLoS One. 2021;16:e0245715.
    >> Share

  139. CHAMBARA N, Liu SYW, Lo X, Ying M, et al
    Diagnostic performance evaluation of different TI-RADS using ultrasound computer-aided diagnosis of thyroid nodules: An experience with adjusted settings.
    PLoS One. 2021;16:e0245617.
    >> Share

  140. MOHAMMADI N, Alimohammadian M, Feizesani A, Poustchi H, et al
    The marginal causal effect of opium consumption on the upper gastrointestinal cancer death using parametric g-formula: An analysis of 49,946 cases in the Golestan Cohort Study, Iran.
    PLoS One. 2021;16:e0246004.
    >> Share

  141. MILANI V, Zara ALSA, da Silva EN, Cardoso LB, et al
    Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.
    PLoS One. 2021;16:e0246475.
    >> Share

  142. CHENG PC, Chang CM, Liao LJ, Cheng PW, et al
    The outcomes and decision-making process for neck lymph nodes with indeterminate fine-needle aspiration cytology.
    PLoS One. 2021;16:e0246437.
    >> Share

  143. WALLANDER K, Eisfeldt J, Lindblad M, Nilsson D, et al
    Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    PLoS One. 2021;16:e0245488.
    >> Share

  144. EVEN C, Sagaon Teyssier L, Pointreau Y, Temam S, et al
    Factors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 2012.
    PLoS One. 2021;16:e0246252.
    >> Share

  145. LIU CH, Chang JT, Lee TH, Chang PY, et al
    Total plaque score helps to determine follow-up strategy for carotid artery stenosis progression in head and neck cancer patients after radiation therapy.
    PLoS One. 2021;16:e0246684.
    >> Share

  146. HUTAJULU SH, Howdon D, Taroeno-Hariadi KW, Hardianti MS, et al
    Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study.
    PLoS One. 2021;16:e0246638.
    >> Share

  147. SUN Z, Nyberg R, Wu Y, Bernard B, et al
    Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
    PLoS One. 2021;16:e0247238.
    >> Share

  148. NANNAPANENI S, Griffith CC, Magliocca KR, Chen W, et al
    Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    PLoS One. 2021;16:e0247498.
    >> Share

  149. KUO CY, Lee CC, Lee YL, Liou SC, et al
    Visual light perceptions caused by medical linear accelerator: Findings of machine-learning algorithms in a prospective questionnaire-based case-control study.
    PLoS One. 2021;16:e0247597.
    >> Share

  150. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    >> Share

  151. AL-SALAM S, Sharma C, Abu Sa'a MT, Afandi B, et al
    Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.
    PLoS One. 2021;16:e0247807.
    >> Share

  152. AMRENOVA A, Suzuki K, Saenko V, Yamashita S, et al
    Cell competition between anaplastic thyroid cancer and normal thyroid follicular cells exerts reciprocal stress response defining tumor suppressive effects of normal epithelial tissue.
    PLoS One. 2021;16:e0249059.
    >> Share

  153. SHRIDHAR K, Aggarwal A, Rawal I, Gupta R, et al
    Feasibility of investigating the association between bacterial pathogens and oral leukoplakia in low and middle income countries: A population-based pilot study in India.
    PLoS One. 2021;16:e0251017.
    >> Share

  154. LORENZATTI HILES G, Chang KP, Bellile EL, Wang CI, et al
    Understanding the impact of high-risk human papillomavirus on oropharyngeal squamous cell carcinomas in Taiwan: A retrospective cohort study.
    PLoS One. 2021;16:e0250530.
    >> Share

  155. YAGYUU T, Funayama N, Imada M, Kirita T, et al
    Effect of smoking status and programmed death-ligand 1 expression on the microenvironment and malignant transformation of oral leukoplakia: A retrospective cohort study.
    PLoS One. 2021;16:e0250359.
    >> Share

  156. LEE PY, Lai JN, Chiu LT, Wei YT, et al
    Incidence and time trends of herpes zoster among patients with head and neck cancer who did and did not undergo radiotherapy: A population-based cohort study.
    PLoS One. 2021;16:e0250724.
    >> Share

  157. BAE YJ, Kim TE, Choi BS, Jeong WJ, et al
    Comprehensive assessments of the open mouth dynamic maneuver and metal artifact reduction algorithm on computed tomography images of the oral cavity and oropharynx.
    PLoS One. 2021;16:e0248696.
    >> Share

  158. SHIN YJ, Vu H, Lee JH, Kim HD, et al
    Diagnostic and prognostic ability of salivary MMP-9 for oral squamous cell carcinoma: A pre-/post-surgery case and matched control study.
    PLoS One. 2021;16:e0248167.
    >> Share

  159. CAMPOS-DELGADO DU, Gutierrez-Navarro O, Salinas-Martinez R, Duran E, et al
    Blind deconvolution estimation by multi-exponential models and alternated least squares approximations: Free-form and sparse approach.
    PLoS One. 2021;16:e0248301.
    >> Share

  160. ZHEN J, Song Z, Su W, Zeng QC, et al
    Integrated analysis of RNA-binding proteins in thyroid cancer.
    PLoS One. 2021;16:e0247836.
    >> Share

  161. HOSHINO I, Ishige F, Iwatate Y, Gunji H, et al
    Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma.
    PLoS One. 2021;16:e0248016.
    >> Share

  162. SHIMADA Y, Matsubayashi J, Saito A, Ohira T, et al
    Small RNA sequencing to differentiate lung squamous cell carcinomas from metastatic lung tumors from head and neck cancers.
    PLoS One. 2021;16:e0248206.
    >> Share

  163. HAN S, Jin S, Yoo SH, Lee HS, et al
    A practical individualized radiation precaution based on the dose rate at release time after inpatient 131I ablation therapy.
    PLoS One. 2021;16:e0251627.
    >> Share

  164. SASAKI F, Kanmura S, Oda K, Maeda H, et al
    Acetaldehyde breath test as a cancer risk marker in patients with esophageal and hypopharyngeal squamous cell carcinoma.
    PLoS One. 2021;16:e0251457.
    >> Share

  165. WANG B, Tang D, Liu Z, Wang Q, et al
    LINC00958 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of oesophageal squamous cell carcinoma cells.
    PLoS One. 2021;16:e0251797.
    >> Share

  166. PAO TH, Chen YY, Chang WL, Chang JS, et al
    Esophageal fistula after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal squamous cell carcinoma.
    PLoS One. 2021;16:e0251811.
    >> Share

  167. HU Y, Ai LS, Zhou LQ
    Prognostic value of FGFR1 expression and amplification in patients with HNSCC: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0251202.
    >> Share

  168. ZHOU Y, Tian M, Gungor C, Wang D, et al
    Neoadjuvant radiotherapy for locoregional Siewert type II gastroesophageal junction adenocarcinoma: A propensity scores matching analysis.
    PLoS One. 2021;16:e0251555.
    >> Share

  169. RANKOVIC N, Todorovic J, Simic R
    Clinical and ultrasound characteristics of pediatric lateral neck masses.
    PLoS One. 2021;16:e0251563.
    >> Share

  170. CHANG SW, Tsai YH, Hsu CM, Huang EI, et al
    Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
    PLoS One. 2021;16:e0251455.
    >> Share

  171. GUADIANA D, Kavanagh NM, Squarize CH
    Oral health care professionals recommending and administering the HPV vaccine: Understanding the strengths and assessing the barriers.
    PLoS One. 2021;16:e0248047.
    >> Share

  172. CHEONG TY, Hong SD, Jung KW, So YK, et al
    The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size.
    PLoS One. 2021;16:e0251446.
    >> Share

  173. JIANG Y, Zhang C, Shen W, Li Y, et al
    Identification of serum prognostic marker miRNAs and construction of microRNA-mRNA networks of esophageal cancer.
    PLoS One. 2021;16:e0255479.
    >> Share

  174. MATSUNAGA H, Orita M, Taira Y, Takamura N, et al
    Risk perception of the pre-distribution of stable iodine to guardians of children living around the Genkai Nuclear Power Plant, Saga Prefecture, Japan.
    PLoS One. 2021;16:e0250570.
    >> Share

  175. YOON JK, Jang JY, An YS, Lee SJ, et al
    Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
    PLoS One. 2021;16:e0254844.
    >> Share

  176. GEENS M, Stappers S, Konings H, De Winter BY, et al
    Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.
    PLoS One. 2021;16:e0252646.
    >> Share

  177. YU G, Yu W, Xu X, Ye B, et al
    Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis.
    PLoS One. 2021;16:e0252829.
    >> Share

  178. LIN S, Liu T, Chen J, Li G, et al
    Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis.
    PLoS One. 2021;16:e0252751.
    >> Share

  179. FANG L, Shi L, Wang W, Wu X, et al
    Low expression of CIP4 in predicting worse overall survival: A potential biomarker for laryngeal cancer.
    PLoS One. 2021;16:e0253545.
    >> Share

  180. MIARI R, Azzam N, Bar-Shalom R, Fares F, et al
    5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line.
    PLoS One. 2021;16:e0253756.
    >> Share

  181. LEE H, Paeng JC, Choi H, Cho SW, et al
    Effect of TSH stimulation protocols on adequacy of low-iodine diet for radioiodine administration.
    PLoS One. 2021;16:e0256727.
    >> Share

  182. OMIDVARI AH, Lansdorp-Vogelaar I, de Koning HJ, Meester RGS, et al
    Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration.
    PLoS One. 2021;16:e0253893.
    >> Share

  183. PAN XB, Huang ST, Qu S, Chen KH, et al
    Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma.
    PLoS One. 2021;16:e0253424.
    >> Share

  184. DE C FERREIRA C, Dufloth R, de Carvalho AC, Reis RM, et al
    Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma.
    PLoS One. 2021;16:e0253418.
    >> Share

  185. KIM HB, Kim GJ, Han KD, Joo YH, et al
    Changes in metabolic syndrome status and risk of laryngeal cancer: A nationwide cohort study.
    PLoS One. 2021;16:e0252872.
    >> Share

  186. SHINOHARA Y, Washio J, Kobayashi Y, Abiko Y, et al
    Hypoxically cultured cells of oral squamous cell carcinoma increased their glucose metabolic activity under normoxic conditions.
    PLoS One. 2021;16:e0254966.
    >> Share

  187. ALLEN DZ, Aljabban J, Silverman D, McDermott S, et al
    Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis.
    PLoS One. 2021;16:e0258187.
    >> Share

  188. BOHLAND M, Tharun L, Scherr T, Mikut R, et al
    Machine learning methods for automated classification of tumors with papillary thyroid carcinoma-like nuclei: A quantitative analysis.
    PLoS One. 2021;16:e0257635.
    >> Share

  189. MEYER TJ, Gerhard-Hartmann E, Lodes N, Scherzad A, et al
    Pilot study on the value of Raman spectroscopy in the entity assignment of salivary gland tumors.
    PLoS One. 2021;16:e0257470.
    >> Share

  190. CUI Y, Kim HS, Cho ES, Han D, et al
    Longitudinal detection of somatic mutations in saliva and plasma for the surveillance of oral squamous cell carcinomas.
    PLoS One. 2021;16:e0256979.
    >> Share

  191. MUNSAMY Y, Seedat RY, Sekee TR, Bester PA, et al
    Complete genome sequence of a HPV31 isolate from laryngeal squamous cell carcinoma and biological consequences for p97 promoter activity.
    PLoS One. 2021;16:e0252524.
    >> Share

  192. SCHUON R, Schwarzensteiner J, Paasche G, Lenarz T, et al
    Functional aspects of the Eustachian tube by means of 3D-modeling.
    PLoS One. 2021;16:e0244909.
    >> Share

  193. DICKEY BL, Sirak B, Martin-Gomez L, Reich RR, et al
    Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.
    PLoS One. 2021;16:e0254161.
    >> Share

  194. TAKENAKA Y, Takemoto N, Oya R, Inohara H, et al
    Prognostic impact of sarcopenia in patients with head and neck cancer treated with surgery or radiation: A meta-analysis.
    PLoS One. 2021;16:e0259288.
    >> Share

  195. MEIER V, Czichon F, Walsh L, Rohrer Bley C, et al
    Can volumetric modulated arc radiation therapy reduce organ at risk dose in stage 4 sinonasal tumors in dogs treated with boost irradiation?
    PLoS One. 2021;16:e0259112.
    >> Share

  196. SHI Y, Zhang Y, Niu Y, Chen Y, et al
    Prognostic role of the prognostic nutritional index (PNI) in patients with head and neck neoplasms undergoing radiotherapy: A meta-analysis.
    PLoS One. 2021;16:e0257425.
    >> Share

  197. DENNING SK, Valleau MA, Pelowski WJ, Chaisson CM, et al
    An automatic water-occluding device to enable laryngectomee participation in water activities.
    PLoS One. 2021;16:e0257463.
    >> Share

  198. PLOYPETCH S, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Salivary proteomics in monitoring the therapeutic response of canine oral melanoma.
    PLoS One. 2021;16:e0256167.
    >> Share

  199. KIM TY, Lee JY, Lee YJ, Park DW, et al
    CT texture analysis of tonsil cancer: Discrimination from normal palatine tonsils.
    PLoS One. 2021;16:e0255835.
    >> Share

  200. STAIRS DB, Landmesser ME, Aliaga C, Chen KM, et al
    Black raspberry restores the expression of the tumor suppressor p120ctn in the oral cavity of mice treated with the carcinogen dibenzo[a,l]pyrene diol epoxide.
    PLoS One. 2021;16:e0259998.
    >> Share

  201. ARORA C, Kaur D, Naorem LD, Raghava GPS, et al
    Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway.
    PLoS One. 2021;16:e0259534.
    >> Share

  202. TAMIN S, Adham M, Noer A, Supriana N, et al
    Upright epiglottis prevents aspiration in patients with nasopharyngeal carcinoma post-chemoradiation.
    PLoS One. 2021;16:e0261110.
    >> Share

  203. WU CN, Wu SC, Chen WC, Yang YH, et al
    Angiotensin II receptor blockers and oral squamous cell carcinoma survival: A propensity-score-matched cohort study.
    PLoS One. 2021;16:e0260772.
    >> Share

  204. YAO C, Li Y, Luo L, Xiong Q, et al
    Identification of miRNAs and genes for predicting Barrett's esophagus progressing to esophageal adenocarcinoma using miRNA-mRNA integrated analysis.
    PLoS One. 2021;16:e0260353.
    >> Share

  205. YOSHIDA K, Kodama Y, Tanaka Y, Pak K, et al
    Pharmacist involved education program in a multidisciplinary team for oral mucositis: Its impact in head-and-neck cancer patients.
    PLoS One. 2021;16:e0260026.
    >> Share

  206. LIM YJ, Kong M
    Population-based comparative survival analysis of surgery with or without adjuvant radiotherapy and non-operative primary radiotherapy in patients with early-stage oral tongue squamous cell carcinoma.
    PLoS One. 2021;16:e0259384.
    >> Share

  207. LIU KYP, Zhu SY, Harrison A, Chen ZY, et al
    Quantitative nuclear phenotype signatures predict nodal disease in oral squamous cell carcinoma.
    PLoS One. 2021;16:e0259529.
    >> Share

  208. GOVINDARAJ PK, Kallarakkal TG, Mohd Zain R, Tilakaratne WM, et al
    Expression of Ki-67, Cornulin and ISG15 in non-involved mucosal surgical margins as predictive markers for relapse in oral squamous cell carcinoma (OSCC).
    PLoS One. 2021;16:e0261575.
    >> Share

  209. KANETAKE H, Kato-Kogoe N, Terada T, Kurisu Y, et al
    Short communication: Distribution of phospholipids in parotid cancer by matrix-assisted laser desorption/ionization imaging mass spectrometry.
    PLoS One. 2021;16:e0261491.
    >> Share

  210. YOON J, Choi Y, Jang J, Shin NY, et al
    Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.
    PLoS One. 2021;16:e0261233.
    >> Share

  211. FAHEY PP, Page A, Astell-Burt T, Stone G, et al
    Imputing pre-diagnosis health behaviour in cancer registry data and investigating its relationship with oesophageal cancer survival time.
    PLoS One. 2021;16:e0261416.
    >> Share

  212. FAN R, Dong L, Li P, Wang X, et al
    Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma.
    PLoS One. 2021;16:e0251962.
    >> Share

  213. LIU Y, Geng H, Liu X, Cao M, et al
    A meta-analysis of circulating microRNAs in the diagnosis of papillary thyroid carcinoma.
    PLoS One. 2021;16:e0251676.
    >> Share

  214. RAMAN S, Shafie AA, Abraham MT, Shim CK, et al
    Provider cost of treating oral potentially malignant disorders and oral cancer in Malaysian public hospitals.
    PLoS One. 2021;16:e0251760.
    >> Share

  215. PHILIPPRON A, Depypere L, Oeyen S, De Laere B, et al
    Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma.
    PLoS One. 2021;16:e0251052.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016